ELV vs TELO · P/E 18, rev $199.13B vs $86.0M cap
Elevance Health Inc (ELV) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
TELO does not have a complete income-statement cache yet.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. TELO currently screens at market cap $86.0M.
Not investment advice. Open the ELV and TELO stock pages for the full models.
Not investment advice.